Item

A phase 2 study of pemigatinib for pre-treated glioblastoma or other gliomas with activating FGFR1-3 alterations: Results from FIGHT-209

Franceschi, E.
; 
van den Bent, M. J.
; 
Sanson, M.
; 
Lassman, A. B.
; 
Lombardi, G.
; 
Villar, M. V.
; 
Strowd, R. E.
; 
Sanchez, J. M. S.
; 
McBain, C.
; 
Dahlrot, R. H.
... show 10 more
Citations
Google Scholar:
Lookup
Altmetric:
Abstract
Authors
Franceschi, E.
van den Bent, M. J.
Sanson, M.
Lassman, A. B.
Lombardi, G.
Villar, M. V.
Strowd, R. E.
Sanchez, J. M. S.
McBain, C.
Dahlrot, R. H.
Pineda, E.
Larrieu, D.
Pellerino, A.
Narita, Y.
Bagley, S. J.
Yogendran, L.
Oliveira, N.
Guo, Y. F.
Viviers, L.
Ahluwalia, M. S.
Affiliation
IRCCS Ist Sci Neurolog Bologna, Bologna, Italy Erasmus MC Canc Inst, Rotterdam, Netherlands Hop Univ Pitie Salpetriere, Paris, France Columbia Univ, Dept Neurol, Div Neurooncol, Vagelos Coll Phys & Surg, New York, NY USA Columbia Univ, Herbert Irving Comprehens Canc Ctr, Vagelos Coll Phys & Surg, New York, NY USA New York Presbyterian, New York, NY USA IOV Ist Oncol Veneto, Dept Oncol, Padua, Italy Hosp Gen Univ Vall dHebron, Barcelona, Spain Wake Forest Univ, Dept Pathol, Bowman Gray Sch Med, Winston Salem, NC USA Hosp Univ 12 Octubre, Madrid, Spain Christie NHS Fdn Trust, Manchester, England Odense Univ Hosp, Dept Oncol, Odense, Denmark Hosp Clin Barcelona, Barcelona, Spain Inst Univ Canc Toulouse Oncopole, Oncopole Claudius Regaud, Toulouse, France Rita Levi Montalcini Univ, Div Neurooncol, Dept Neurosci, Turin, Italy City Hlth & Sci Hosp, Turin, Italy Natl Canc Ctr, Tokyo, Japan Univ Penn Hosp, Philadelphia, PA USA UC Hlth Cincinnati, Cincinnati, OH USA Incyte Biosci Int, Morges, Switzerland Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA
Description
Date
2025
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Franceschi E, van den Bent MJ, Sanson M, Lassman AB, Lombardi G, Villar MV, et al. A phase 2 study of pemigatinib for pre-treated glioblastoma or other gliomas with activating FGFR1-3 alterations: Results from FIGHT-209. JOURNAL OF CLINICAL ONCOLOGY. 2025 JUN 1;43(16_SUPPL):2003-. PubMed PMID: WOS:001509565300001. English.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/627450
Embedded videos